Manulife (Manufacturers Life Insurance)’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,589,508
| Closed | -$12.5M | – | 3010 |
|
|
2020
Q1 | $12.5M | Buy |
2,589,508
+2,421
| +0.1% | +$15.7K | 0.01% | 641 |
|
|
2019
Q4 | $27.5M | Sell |
2,587,087
-182,228
| -7% | -$1.81M | 0.03% | 464 |
|
|
2019
Q3 | $30.3M | Buy |
2,769,315
+1,528,260
| +123% | +$20M | 0.03% | 439 |
|
|
2019
Q2 | $19M | Buy |
1,241,055
+27,638
| +2% | +$400K | 0.02% | 567 |
|
|
2019
Q1 | $15.6M | Buy |
1,213,417
+129,824
| +12% | +$1.47M | 0.02% | 641 |
|
|
2018
Q4 | $10.3M | Buy |
1,083,593
+990,310
| +1,062% | +$12.8M | 0.01% | 768 |
|
|
2018
Q3 | $1.55M | Buy |
93,283
+71,467
| +328% | +$1.15M | ﹤0.01% | 1557 |
|
|
2018
Q2 | $351K | Buy |
21,816
+1,420
| +7% | +$25.3K | ﹤0.01% | 2670 |
|
|
2018
Q1 | $312K | Buy |
20,396
+2,177
| +12% | +$33.9K | ﹤0.01% | 2694 |
|
|
2017
Q4 | $285K | Sell |
18,219
-1,280
| -7% | -$17.1K | ﹤0.01% | 2745 |
|
|
2017
Q3 | $216K | Buy |
19,499
+220
| +1% | +$2.07K | ﹤0.01% | 2921 |
|
|
2017
Q2 | $178K | Buy |
19,279
+5,522
| +40% | +$46K | ﹤0.01% | 3107 |
|
|
2017
Q1 | $118K | Buy |
13,757
+2,074
| +18% | +$18.9K | ﹤0.01% | 3118 |
|
|
2016
Q4 | $125K | Buy |
11,683
+7,691
| +193% | +$93K | ﹤0.01% | 3115 |
|
|
2016
Q3 | $43K | Buy |
+3,992
| New | +$32.5K | ﹤0.01% | 3426 |
|
|
2016
Q2 | – | Sell |
-7,665
| Closed | -$34K | – | 4383 |
|
|
2016
Q1 | $34K | Sell |
7,665
-3,607
| -32% | -$17.6K | ﹤0.01% | 3385 |
|
|
2015
Q4 | $71K | Buy |
11,272
+392
| +4% | +$3.18K | ﹤0.01% | 3201 |
|
|
2015
Q3 | $96K | Hold |
10,880
| – | – | ﹤0.01% | 3145 |
|
|
2015
Q2 | $128K | Buy |
10,880
+698
| +7% | +$9.69K | ﹤0.01% | 3205 |
|
|
2015
Q1 | $147K | Buy |
10,182
+2,338
| +30% | +$35.8K | ﹤0.01% | 2965 |
|
|
2014
Q4 | $134K | Sell |
7,844
-820
| -9% | -$11.8K | ﹤0.01% | 2926 |
|
|
2014
Q3 | $108K | Buy |
8,664
+64
| +0.7% | +$788 | ﹤0.01% | 3062 |
|
|
2014
Q2 | $126K | Buy |
8,600
+952
| +12% | +$14.6K | ﹤0.01% | 3063 |
|
|
2014
Q1 | $156K | Buy |
7,648
+247
| +3% | +$5.99K | ﹤0.01% | 2869 |
|
|
2013
Q4 | $145K | Buy |
7,401
+378
| +5% | +$10.1K | ﹤0.01% | 2915 |
|
|
2013
Q3 | $318K | Sell |
7,023
-77
| -1% | -$2.51K | ﹤0.01% | 2294 |
|
|
2013
Q2 | $169K | Buy |
+7,100
| New | +$113K | ﹤0.01% | 2705 |
|
Manulife (Manufacturers Life Insurance)'s STML Position: Q2 2020 in Review
Manulife (Manufacturers Life Insurance) sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 2,589,508 shares — an estimated $12.5M sold.
Manulife (Manufacturers Life Insurance) first reported a position in STML in Q2 2013 and held it in 27 quarters. The position peaked at $30.3M in Q3 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- Manulife (Manufacturers Life Insurance) reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 2,589,508 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $12.5M.
- Manulife (Manufacturers Life Insurance) first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 27 quarters.
- Manulife (Manufacturers Life Insurance)'s Stemline Therapeutics, Inc. position peaked at $30.3M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2020, filed 10 Aug 2020.